Veritas In Silico Inc. [130A.T]
TOKYO, Apr 22 (Pulse News Wire) – Veritas In Silico (130A.T) completed the relocation and renovation of its New Kawasaki Institute, now operating as the Kawasaki Institute near JR Kawasaki Station since April. The institute's inauguration ceremony was held on April 22.
The move, costing the largest amount among planned investments in 2026, enhances research capabilities with advanced facilities designed specifically for fragile RNA studies and integrated AI technologies. The Kawasaki Institute, located at 66-2 Koyo Kawasaki Minami Building, expands the company’s research capacity fourfold compared to previous facilities.
It supports strategic research initiatives aimed at fostering long-term shareholder value through enhanced drug discovery platforms and AI-driven pharmaceutical development. "This relocation marks a significant step towards strengthening our research infrastructure and supporting future growth," commented Shino Ameu, Director of the Kawasaki Institute.
"We are grateful for the support received during this transition." The costs associated with the relocation are included in the fiscal year 2026 performance forecasts previously disclosed, and are not expected to significantly impact the company's financial condition or operational results.
🟢 Confidence: High AI-translated content.